Affiliation:
1. Dipartimento di Scienze della Vita e dell'Ambiente, Universita Politecnica delle Marche, Ancona, Italy
2. Departamento de Fisica Geral, Instituto de Fisica, Universidade de São Paulo, Sao Paulo, Brazil
Abstract
Starting from the second half of the 1900s, the advent of nanotechnology in medicine has provoked a
profound revolution in this area; at present, nanomedicine delivered a remarkably large set of research and clinically
useful tools as diagnostic devices, contrast agents, analytical tools, physical therapy applications, and drugdelivery
vehicles. Concerning nanoformulations for drug delivery, they are constituted by nanoparticles with
dimensions lower than 1 μm, usually characterized by improved pharmacokinetics, taking advantage of specific
targeting, and reduced side effects. The contributors to the present chapter are reviewing a range of papers related
to the structural characterization of nanoformulations by X-ray diffraction techniques. The whole of the considered
papers underlines the essential role that biophysical techniques have acquired as an essential prerequisite to
understanding stability, bioavailability, and lipid, biopolymer, and drug organization in nanoformulations.
Funder
FAPESP
National Council for Scientific and Technological Development
Publisher
Bentham Science Publishers Ltd.
Subject
Drug Discovery,Pharmacology
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献